by
HeartHawk on Heart Disease
Tuesday, November 23 2010
The study known as the "Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin" (JUPITER), was a classical large, long-term, double-blind, placebo-controlled, randomized clinical trial designed to determine whether it made sense to start statin treatment (in this case 20 mg of rosuvastatin or... Read more
by
HeartHawk on Heart Disease
Monday, August 16 2010
Wow! Is this what heart healthcare is coming to? I just finished reading a report published in the American Journal of Cardiology suggesting that a statin be offered with fast food orders as a means of countering the unhealthy effects such dubious diet choices can have on the heart.
The study comes from the prestigious... Read more
by
HeartHawk on Heart Disease
Monday, May 17 2010
I love cruise ship vacationing and generally take at least one cruise per year. Having traveled with virtually every major cruise line I have had several discussions with heart disease prevention professionals and patient groups about vacationing or attending conferences on cruise ships and thought I would use the opportunity created by my... Read more
by
HeartHawk on Heart Disease
Friday, April 02 2010
As both a blogger and a patient "living with heart disease" the recent announcement (see HealthCentral.com report) of the success of the new anti-cholesterol drug "eprotirome" is the most exciting news I have come across in quite some time. However, the article's headline "Statin Alternative Shows Promise in New Study" tells only half the... Read more
by
HeartHawk on Heart Disease
Wednesday, December 09 2009
Few disease conditions are so thoroughly intertwined as coronary artery disease (CAD) and diabetes. The link between diabetes and heart disease is well-established. If you have diabetes your CAD risk skyrockets. More importantly, even without a diagnosis of diabetes, you may still have a significantly elevated risk. Once... Read more
